Binge Eating Disorder: More Than Willpower

Binge eating disorder (BED) is the most common eating disorder in the United States, affecting an estimated 2.8 million people. It's more common than anorexia and bulimia combined. And yet, most people have never heard of it — or if they have, they dismiss it as "just overeating."

It's not just overeating. It's a recognized psychiatric disorder that causes real suffering, carries significant medical consequences, and responds to specific treatments. If you or someone you know struggles with episodes of uncontrollable eating followed by intense shame and distress, this article is for you.

What Binge Eating Disorder Actually Is

BED is characterized by recurrent episodes of eating significantly more food than most people would eat in a similar period, accompanied by a feeling of loss of control. The diagnostic criteria (DSM-5) require:

During binge episodes, at least three of the following:

• Eating much more rapidly than normal
• Eating until uncomfortably full
• Eating large amounts when not physically hungry
• Eating alone due to embarrassment about how much you're eating
• Feeling disgusted, depressed, or guilty afterward

Additional criteria:

• Marked distress about the binge eating
• Episodes occur at least once per week for three months
• Not associated with compensatory behaviors (purging, excessive exercise) — that's what distinguishes BED from bulimia

What a binge actually looks like:

A binge isn't having two slices of pizza instead of one. It's eating an entire pizza, then a pint of ice cream, then whatever else is in the kitchen — and feeling completely unable to stop even though you know you want to. It often happens in private, sometimes planned in advance (buying specific "binge foods"), and is always followed by significant emotional distress.

The key feature is the loss of control. It's not about enjoying food — most people describe the experience as numb, dissociative, or even frantic. The pleasure is minimal. The shame afterward is enormous.

Why BED Is Under-Recognized

Several factors keep BED in the shadows:

Weight bias: Many people with BED are in larger bodies, and their eating patterns get written off as a "willpower problem" rather than a clinical condition. Doctors may focus on weight loss advice without ever screening for binge eating.

Shame and secrecy: Binge eating typically happens alone, and people with BED are often experts at hiding it. They may eat normally in front of others and binge in private.

Misconception about eating disorders: The cultural image of eating disorders skews toward young, thin, white women with anorexia. BED affects all genders, ages, races, and body sizes.

Overlap with emotional eating: Everyone occasionally eats for comfort. The line between emotional eating and BED is about frequency, intensity, loss of control, and distress. BED is not a bad habit — it's a disorder with neurobiological underpinnings.

The Biology Behind BED

BED isn't simply about food. Research has identified several neurobiological factors:

Dopamine dysregulation: The same reward circuitry involved in substance use disorders appears to be dysregulated in BED. During binges, there's a surge in dopamine that reinforces the behavior, creating a compulsive loop similar to addiction.

Impaired prefrontal cortex function: The brain regions responsible for impulse control and decision-making show reduced activity in people with BED, particularly during food-related cues.

Hormonal factors: Disruptions in ghrelin (hunger hormone), leptin (satiety hormone), and cortisol (stress hormone) have been documented. This isn't "just eat less" territory — the hormonal signals that should tell you to stop are misfiring.

Genetics: BED runs in families, with heritability estimated at 40-60%. Having a first-degree relative with any eating disorder or with obesity significantly increases risk.

Understanding the biology matters because it shifts the conversation from blame to treatment. You wouldn't tell someone with diabetes to "just produce more insulin." The same logic applies here.

Treatment Options

Psychotherapy

Cognitive Behavioral Therapy (CBT): The most evidence-based therapy for BED. A [2022 meta-review of meta-analyses](https://pubmed.ncbi.nlm.nih.gov/36084848/) identified psychotherapy (especially CBT) and lisdexamfetamine as the interventions with the best evidence over active controls for BED. CBT targets the thoughts, feelings, and situations that trigger binge episodes. It also addresses the cycle of restriction and binge — many people with BED alternate between strict dieting and binge episodes, and the restriction actually fuels the binges.

A typical CBT program for BED includes:

• Self-monitoring of eating patterns and triggers
• Establishing regular, structured eating (3 meals, 2-3 snacks)
• Identifying and challenging distorted thoughts about food, body image, and self-worth
• Developing alternative coping strategies for emotional triggers
• Relapse prevention planning

Interpersonal Therapy (IPT): Focuses on relationship patterns and interpersonal problems that contribute to binge eating. It's particularly effective for people whose binges are triggered by loneliness, conflict, or role transitions.

Dialectical Behavior Therapy (DBT): Originally developed for borderline personality disorder, DBT skills — particularly distress tolerance and emotion regulation — transfer well to BED. If your binges are primarily driven by intense emotions you don't know how to manage, DBT-based approaches may be especially helpful.

Medication

Lisdexamfetamine (Vyvanse): The only FDA-approved medication specifically for BED. Originally developed for ADHD, lisdexamfetamine was found to significantly reduce binge episodes and obsessive-compulsive eating behaviors. A [randomized clinical trial in JAMA Psychiatry](https://pubmed.ncbi.nlm.nih.gov/25587645/) showed 42-50% of adults on 50-70 mg achieved at least four weeks of binge-eating cessation, compared with 21% on placebo.

What the research shows:

• Reduces binge eating days per week by approximately 50-70% in responders
• Also reduces obsessive thoughts about food and compulsive eating behaviors
• Effects are seen within 1-2 weeks, with maximum benefit around 4 weeks
• Effective across a range of BMIs — it's approved for BED, not for weight loss

Important considerations:

• It's a Schedule II controlled substance (stimulant), so it requires careful prescribing and monitoring
• Not appropriate for people with a history of stimulant abuse, certain heart conditions, or uncontrolled anxiety
• Common side effects include dry mouth, insomnia, decreased appetite, and increased heart rate
• It's a prodrug of dextroamphetamine, designed to reduce abuse potential
• Should not be used in combination with MAOIs

SSRIs: While not FDA-approved specifically for BED, SSRIs like sertraline and fluoxetine have shown modest benefit in reducing binge frequency. They're particularly useful when BED coexists with depression or anxiety, which it often does. At higher doses (similar to OCD dosing), they can reduce the obsessive-compulsive quality of binge urges.

Topiramate (Topamax): An anticonvulsant that's been studied for BED and shows significant reduction in binge frequency and associated weight loss. However, cognitive side effects ("brain fog," word-finding difficulty) limit its tolerability for many patients. It's used off-label and typically reserved for people who haven't responded to first-line treatments.

The GLP-1 Crossover

Here's where things get interesting. GLP-1 receptor agonists — medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) — were developed for diabetes and obesity. But patients and clinicians started noticing something unexpected: these medications dramatically reduced the compulsive quality of food thoughts.

What GLP-1 medications do that's relevant to BED:

• Slow gastric emptying, which increases fullness signals
• Act on brain reward centers, reducing the dopaminergic "pull" toward food
• Reduce "food noise" — the constant background chatter of food-related thoughts
• May reduce alcohol cravings and other addictive behaviors through similar mechanisms

The evidence so far:

Research specifically on GLP-1s for BED is still emerging, but preliminary data is encouraging. Several clinical trials are underway. Anecdotal reports from both patients and clinicians suggest significant reductions in binge frequency and severity.

Important caveats:

• GLP-1 medications are not FDA-approved for BED (yet)
• They carry their own side effects — nausea, gastrointestinal issues, and rare but serious risks
• If the underlying psychological drivers of binge eating aren't addressed, binge patterns may return if the medication is stopped
• Insurance coverage varies and these medications remain expensive
• They should be part of a comprehensive treatment plan, not a standalone solution

At CORAL, Dr. Kim stays current on the evolving evidence for GLP-1 medications across multiple conditions, including their potential role in disordered eating. If you're interested in exploring whether these medications might be appropriate for your situation, he can discuss the current evidence and risks honestly.

The Diet Trap

One of the most counterintuitive aspects of BED treatment is this: dieting makes it worse.

Restrictive eating — whether it's calorie counting, eliminating food groups, or intermittent fasting — is one of the strongest predictors of binge episodes. The deprivation triggers a biological and psychological response that leads to binge eating, followed by guilt, followed by more restriction, followed by more bingeing. It's a cycle, and the entry point is restriction.

Effective BED treatment typically involves:

• Stopping all restrictive dieting
• Eating regular, adequate meals and snacks
• Removing the moral judgment from food ("good" foods vs. "bad" foods)
• Focusing on health behaviors rather than weight

This doesn't mean nutrition doesn't matter or that weight concerns are irrelevant. It means that trying to lose weight while actively binge eating is like trying to bail water while drilling holes in the boat. Treat the BED first.

When BED Coexists with Other Conditions

BED rarely travels alone. Common co-occurring conditions include:

• Depression (up to 50% of people with BED)
• Anxiety disorders (up to 37%)
• ADHD (strong overlap — impulsivity is a shared feature)
• PTSD/trauma history (binge eating as a coping mechanism)
• Substance use disorders (shared reward circuitry)
• Obesity (though not everyone with BED has obesity, and not everyone with obesity has BED)

Treatment needs to address the full picture. Treating depression without addressing the binge eating, or vice versa, usually leads to incomplete recovery.

Getting Help

If this article resonated with you, here are concrete next steps:

1. Don't wait for it to get "bad enough." Early treatment leads to better outcomes. You don't need to be in crisis to deserve help.

1. Get a proper evaluation. BED can be identified through a straightforward clinical interview. Many people have lived with it for years without knowing it had a name and a treatment.

1. Consider medication if therapy alone isn't sufficient. There's no weakness in using pharmacological tools for a neurobiological condition.

1. Find a provider who understands eating disorders. Not all mental health providers are comfortable treating BED. Weight-centric advice ("just eat less") from a provider who doesn't understand the disorder can be actively harmful.

1. Be honest about your eating patterns. The shame around binge eating keeps it hidden. Treatment can't work on what it can't see.

You don't have to keep cycling between restriction and binges, between control and chaos. BED is treatable, and the first step is acknowledging that what you're experiencing isn't a character flaw — it's a medical condition. Schedule a confidential evaluation with Dr. Kim at [coral.clinic/start](https://coral.clinic/start).

---

Sources

• McElroy SL et al. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry, 2015. [PubMed](https://pubmed.ncbi.nlm.nih.gov/25587645/)
• Monteleone AM et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neuroscience and Biobehavioral Reviews, 2022. [PubMed](https://pubmed.ncbi.nlm.nih.gov/36084848/)